Protective effect of an antimicrobial peptide from Mytilus edulis chilensis expressed in Nicotiana tabacum L.
Full Text
Reprint PDF

Keywords

antibacterial peptide
disease resistance
in vivo expression
Nicotiana tabacum L.
Pseudomonassyringae pv. syringae
transgenic tobacco plants

How to Cite

1.
Arenas G, Marshall SH, Espinoza V, Ramírez I, Peña-Cortés H. Protective effect of an antimicrobial peptide from Mytilus edulis chilensis expressed in Nicotiana tabacum L. Electron. J. Biotechnol. [Internet]. 2006 Apr. 15 [cited 2024 Oct. 13];9(2):0-. Available from: https://www.ejbiotechnology.info/index.php/ejbiotechnology/article/view/v9n2-2

Abstract

A "defensin-like" antibacterial peptide from Mytilus edulis chilensis, was sub-cloned into a binary vector for expression in plant tissues. The resulting new clone was electroporated into A. tumefaciens to transform tobacco plants. The presence of the construct in transgenic tobacco lines was demonstrated through RT-PCR, Northern and Western blots. Transformed positive plants were selected and grown for challenging. Tobacco leaves were infiltrated with Pseudomonassyringae pv. syringae and visual lesions determined at different times post-exposure. Of seven plants exposed, four gave variable protection up to seven days post-infection while one of them appears to be fully protected. These results suggest that defensin-like antimicrobial peptides from molluscs are a good source to provide resistance of tobacco plants to Pseudomonassyringae pv. syringae.

Full Text
Reprint PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.